In fact, in the same set of experiments, IL-1R1 is significantly upregulated in MS patients, as previously demonstrated at transcriptional level in naïve and memory CD4 T cells, and in vitro differentiated Th17 cells [19]. This evidence concerns the gene CD4 and myeloid sarcoma.